Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

645 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation: participation of host immune cells.
Satake A, Inoue T, Kubo S, Taniguchi Y, Imado T, Fujioka T, Horiuchi M, Xu Y, Ikegame K, Yoshihara S, Kaida K, Tamaki H, Okada M, Okamura H, Ogawa H. Satake A, et al. Among authors: yoshihara s. Int J Hematol. 2010 Apr;91(3):485-97. doi: 10.1007/s12185-010-0545-5. Epub 2010 Mar 20. Int J Hematol. 2010. PMID: 20300982
Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K, Yoshihara S, Taniguchi Y, Kaida K, Inoue T, Okada M, Taniguchi K, Hasei H, Tamaki H, Fujioka T, Kato R, Soma T, Ogawa H. Ikegame K, et al. Among authors: yoshihara s. Exp Hematol. 2011 Aug;39(8):880-90. doi: 10.1016/j.exphem.2011.05.007. Epub 2011 May 27. Exp Hematol. 2011. PMID: 21689724 Free article. Clinical Trial.
Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT.
Yoshihara S, Maruya E, Taniguchi K, Kaida K, Kato R, Inoue T, Fujioka T, Tamaki H, Ikegame K, Okada M, Soma T, Hayashi K, Fujii N, Onuma T, Kusunoki Y, Saji H, Ogawa H. Yoshihara S, et al. Bone Marrow Transplant. 2012 Apr;47(4):508-15. doi: 10.1038/bmt.2011.131. Epub 2011 Jun 20. Bone Marrow Transplant. 2012. PMID: 21691261 Clinical Trial.
Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation.
Nakata J, Okada M, Tamaki H, Satake A, Kaida K, Yoshihara S, Kato R, Ikegame K, Ogawa H. Nakata J, et al. Among authors: yoshihara s. Leuk Res. 2011 Dec;35(12):1658-9. doi: 10.1016/j.leukres.2011.07.005. Epub 2011 Jul 26. Leuk Res. 2011. PMID: 21794916 No abstract available.
645 results